在第一次复发时,急性髓性白血病的结果和遗传动态
Alex Bataller1, Hagop Kantarjian1, Alexandre Bazinet1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Haematologica
|May 2, 2024
概括
复发性急性髓性白血病 (AML) 患者的治疗结果不佳. 复发时的遗传变化,如TP53突变和异常的肌型,影响生存,突出了更好的预先治疗的需要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 复发性急性髓性白血病 (AML) 具有重大治疗挑战,患者的治疗结果不佳.
- 了解复发性AML的遗传情景和预后因素对于改善存活率至关重要.
研究的目的:
- 综合分析复发性AML患者的遗传动态.
- 确定预测复发后生存结果的因素.
主要方法:
- 分析了875名新诊断的AML患者,重点是164名在初始治疗后复发的患者.
- 在复发时评估遗传突变,型变化和临床数据.
- 统计分析以确定整体存活率的独立风险因素.
主要成果:
- 在复发时,通路信号突变通常会消失,而克隆造血和TP53突变仍然存在.
- 与低强度治疗相比,接受强化前线治疗的患者出现TP53突变的发病率更高.
- 复杂的型,KMT2A重组,短暂的缓解持续时间 (<12个月) 和复发时高白细胞计数是较短生存的独立预测因素.
结论:
- 复发性AML的特点是动态的遗传改变和糟糕的生存率.
- 强化前线治疗可能会增加在复发时出现TP53等特定突变的风险.
- 开发更有效的前线和维持疗法对于预防或更好地管理AML复发至关重要.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
81
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Bone Marrow Sampling and Transplants
326
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
326
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
